ClinicalTrials.gg
Drug

Cevimeline clinical trials

Also written Evoxac.

studies test it
5
open now
0
in phase 3
1
first study started
2001

How each study uses cevimeline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
11 Jan 2000 · EVOXAC · NDA 020989 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Cevimeline
4

Brand

Evoxac
3

Studies by the year they started

5 studies that test it; most in 2009 (3)

Studies that test cevimeline, by start year
YearStudies
20011
20071
20093

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 3
1
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 2

Roxane Laboratories (2) · University of Kentucky (1) · American Academy of Otolaryngology-Head and Neck Surgery Foundation (1) · Daiichi Sankyo (1)

Often tested with

Tested in the same studies.

Pilocarpine (1)

Studies

Open first, then newest update. How each study uses cevimeline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 5

Codes

What other systems call cevimeline · ClinicalTrials.gg INT003427

  • MeSH (NLM) C059240cevimelineConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) K9V0CDQ56ECEVIMELINEConfirmed FDA, NLM
  • RxNorm 44281One source FDA
  • NCI Thesaurus C66873CevimelineOne source FDA

Also registered as cevimeline hydrochloride (UNII P81Q6V85NP · RxNorm 260036).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.